Cost-utility analysis in schizophrenia. Discussion

Conference proceeding

A. G Awad, L. P Voruganti, MAHMOUD Mahmoud, H Meltzer, D Meltzer, DIAMOND Diamond, DOCHERTY Docherty and NEUMANN Neumann

The Journal of clinical psychiatry. Supplement, Vol.60(3), pp.22-28

Pharmacoeconomic factors related to the treatment of schizophrenia

1999

Abstract

Biological and medical sciences

Medical sciences

Neuropharmacology

Pharmacology. Drug treatments

Psycholeptics: tranquillizer, neuroleptic

Psychology. Psychoanalysis. Psychiatry

Psychopharmacology

1 Record Views

Title: Cost-utility analysis in schizophrenia. Discussion
Creators - without role: A. G Awad - University of Toronto
L. P Voruganti - University of Toronto
MAHMOUD Mahmoud - University of Toronto
H Meltzer - University of Toronto
D Meltzer - University of Toronto
DIAMOND Diamond - University of Toronto
DOCHERTY Docherty - University of Toronto
NEUMANN Neumann - University of Toronto
Publication Details: The Journal of clinical psychiatry. Supplement, Vol.60(3), pp.22-28
Conference: Pharmacoeconomic factors related to the treatment of schizophrenia
Publisher: Physicians Postgraduate Press
Grant note: American Psychiatric Association Initiative on Schizophrenia
Identifiers: 9923980708331
Academic Unit: King Khalid University
Language: English
Resource Type: Conference proceeding